Multiple Myeloma Research Foundation   Report issue

Foundation Phase 1 Phase 2
Founded: Norwalk CT United States (1998)

Organization Overview

First Clinical Trial
2011
NCT01410500
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Multiple Myeloma Research Foundation